Phase II study of nab-paclitaxel in refractory small bowel...

Annals of Oncology 2019 / 03 Vol. 30; Iss. 3

Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer

Overman, M J, Adam, L, Raghav, K, Wang, J, Kee, B, Fogelman, D, Eng, C, Vilar, E, Shroff, R, Dasari, A, Wolff, R, Morris, J, Karunasena, E, Pisanic, T R, Azad, N, Kopetz, S
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy221
Date:
March, 2019
File:
PDF, 73 KB
2019
Conversion to is in progress
Conversion to is failed